BIODESIX INC (BDSX)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BIODESIX INC reported revenue of $88.50M, up 24.1% from the prior year. The company ran a net loss, with a net margin of -39.8%. It held $87.48M in total assets against $89.94M in total liabilities.
Key ratios (FY2025)
-31.5%
Operating margin
-39.8%
Net margin
+24.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.50M | $71.32M | $49.09M | $38.21M | $54.51M | $45.56M | $24.55M | — |
| Operating Income | -$27.87M | -$34.50M | -$41.34M | -$50.59M | -$40.94M | -$22.93M | -$26.74M | — |
| Net Income | -$35.27M | -$42.93M | -$52.15M | -$65.45M | -$43.16M | -$65.45M | -$30.73M | — |
| EPS (Diluted) | $-4.67 | $-6.64 | $-0.64 | $-1.55 | $-1.58 | — | — | — |
| Total Assets | $87.48M | $97.24M | $99.10M | $92.91M | $76.10M | $121.07M | $45.03M | — |
| Total Liabilities | $89.94M | $76.37M | $94.52M | $72.30M | $56.37M | $79.90M | $76.21M | — |
| Shareholders' Equity | -$2.46M | $20.88M | $4.58M | $20.61M | $19.73M | $41.17M | -$225.14M | -$194.63M |
| Cash & Equivalents | $18.99M | $26.25M | $26.28M | $43.09M | $32.71M | $62.13M | $5.29M | — |
| Operating Cash Flow | -$23.27M | -$48.65M | -$22.87M | -$44.97M | -$28.22M | -$21.37M | -$21.73M | — |
| Capital Expenditures | $259.0K | $3.23M | $22.92M | $3.30M | $2.24M | $1.95M | $1.31M | — |
| Shares Outstanding | 8.25M | 7.27M | 96.24M | 77.61M | 30.79M | 26.56M | 254.9K | — |